Literature DB >> 8385982

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

S K Kjaer1, E M de Villiers, H Cağlayan, E Svare, B J Haugaard, G Engholm, R B Christensen, K A Møller, P Poll, H Jensen.   

Abstract

The prevalence of human papillomavirus (HPV) infection and other risk factors were studied in a high risk area for cervical cancer (Greenland) and in a low risk area (Denmark). From Nuuk (Greenland) and Nykøbing Falster (Denmark), random samples of 150 women aged 20-39 years were drawn. A total of 129 and 126 women were included in Greenland and Denmark, respectively. The proportion of HPV infected women assessed by ViraPap was similar in Denmark and Greenland (4.8 vs 3.9%). When type specific polymerase chain reaction (PCR) was used, the total HPV detection rate was 38.9% in the Danish population and 43.4% in the Greenlandic. A similar interrelationship between Greenland and Denmark applied to the HPV types 11, 16, 18 and 33. No relationship was observed between HPV detection and number of partners for any of the diagnostic methods. Significantly more Greenlandic than Danish women had antibodies to HSV 2, 76.0% and 26.2%, respectively. The prevalence of self-reported histories of selected venereal diseases was also highest among Greenlanders, except for genital warts where the prevalence was similar in the two areas. Greenlandic women had significantly more sexual partners, earlier age at first intercourse, more current smokers and less use of barrier contraceptives compared to the Danish women. This study confirms the results of our previous population-based cross-sectional comparison study in these areas, corroborating the conclusion that the prevalence of detectable HPV infection does not seem to be a determinant of cervical cancer incidence. However, by using DNA hybridisation techniques, temporal virus shedding is only measured at one point in time. Detectable virus shedding may not correlate with the risk of cervical cancer. In fact, HPV DNA detection may have different implications in different populations. In Denmark, HPV DNA detection may reflect transient, recently acquired infection, whereas in Greenland, it is more indicative of chronic persistent infection.

Entities:  

Mesh:

Year:  1993        PMID: 8385982      PMCID: PMC1968330          DOI: 10.1038/bjc.1993.152

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies.

Authors:  B F Vestergaard; P C Grauballe
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-08

2.  Determinants of genital human papillomavirus infection in young women.

Authors:  C Ley; H M Bauer; A Reingold; M H Schiffman; J C Chambers; C J Tashiro; M M Manos
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

3.  The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection.

Authors:  E L Franco
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

4.  Evolution of in vitro transformation and tumorigenesis of HPV16 and HPV18 immortalized primary cervical epithelial cells.

Authors:  G Pecoraro; M Lee; D Morgan; V Defendi
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

5.  Looking for human papillomavirus type 16 by PCR.

Authors:  M Manos; K Lee; C Greer; J Waldman; N Kiviat; K Holmes; C Wheeler
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

6.  Risk factors for cervical cancer in Greenland and Denmark: a population-based cross-sectional study.

Authors:  S K Kjaer; C Teisen; B J Haugaard; E Lynge; R B Christensen; K A Møller; H Jensen; P Poll; B F Vestergaard; E M de Villiers
Journal:  Int J Cancer       Date:  1989-07-15       Impact factor: 7.396

7.  HL-A types in Danish Eskimos from Greenland.

Authors:  F Kissmeyer-Nielsen; H Andersen; M Hauge; K E Kjerbye; B Mogensen; A Svejgaard
Journal:  Tissue Antigens       Date:  1971

8.  Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study.

Authors:  S K Kjaer; G Engholm; C Teisen; B J Haugaard; E Lynge; R B Christensen; K A Møller; H Jensen; P Poll; B F Vestergaard
Journal:  Am J Epidemiol       Date:  1990-04       Impact factor: 4.897

9.  Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and southern-blot analysis.

Authors:  W Melchers; A van den Brule; J Walboomers; M de Bruin; M Burger; P Herbrink; C Meijer; J Lindeman; W Quint
Journal:  J Med Virol       Date:  1989-04       Impact factor: 2.327

10.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

View more
  8 in total

1.  Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors.

Authors:  P K Chan; M Y Chan; W W Li; D P Chan; J L Cheung; A F Cheng
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Association of human herpes, papilloma and polyoma virus families with bladder cancer.

Authors:  Georgios I Panagiotakis; Danae Papadogianni; Maria N Chatziioannou; Ismini Lasithiotaki; Dimitrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2012-09-13

3.  Herpes simplex infection in urothelial carcinoma.

Authors:  Naomi Kaku; Kenji Kashima; Tsutomu Daa; Iwao Nakayama; Shigeo Yokoyama
Journal:  Virchows Arch       Date:  2004-05-20       Impact factor: 4.064

4.  Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.

Authors:  S A Tonon; M A Picconi; J B Zinovich; D J Liotta; P D Bos; J A Galuppo; L V Alonio; J A Ferreras; A R Teyssié
Journal:  Infect Dis Obstet Gynecol       Date:  1999

5.  Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan.

Authors:  T Sasagawa; Y Dong; K Saijoh; S Satake; M Tateno; M Inoue
Journal:  Jpn J Cancer Res       Date:  1997-04

6.  Human papillomavirus and invasive cervical cancer in Brazil.

Authors:  J Eluf-Neto; M Booth; N Muñoz; F X Bosch; C J Meijer; J M Walboomers
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

7.  Prevalence of human papillomavirus DNA sequences in an area with very high incidence of cervical carcinoma.

Authors:  C C Pao; S M Kao; G C Tang; K Lee; J Si; S Ruan
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

8.  Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014).

Authors:  Sen Li; Xi Wen
Journal:  BMC Cancer       Date:  2017-11-07       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.